规格 价格 库存
 50ul RMB¥ 1800 现货
 100ul RMB¥ 2800 现货

货期: 当天发货



ELISA 1:10000, WB 1:500-1:2000, IHC 1:200-1:1000, IF/ICC 1:200-1:1000, FCM 1:200-1:400
*The optimal dilutions should be determined by the end user.

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

Monoclonal [AFB1916]
C-CBL antibody detects endogenous levels of total C-CBL.
引用格式: Affinity Biosciences Cat# BF0151, RRID:AB_2833939.
Mouse IgG1 in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.


4732447J05Rik; C CBL; Cas Br M (murine) ecotropic retroviral transforming sequence; Casitas B lineage lymphoma proto oncogene; Casitas B-lineage lymphoma proto-oncogene; CBL 2; cbl; CBL_HUMAN; CBL2; E3 ubiquitin protein ligase CBL; E3 ubiquitin-protein ligase CBL; Oncogene CBL2; Proto oncogene c CBL; Proto-oncogene c-CBL; RGD1561386; RING finger protein 55; RNF55; Signal transduction protein CBL;



Purified recombinant fragment of human C-CBL expressed in E. Coli.

The cbl oncogene was first identified as part of a transforming retrovirus which induces mouse pre-B and pro-B cell lymphomas. As an adaptor protein for receptor protein-tyrosine kinases, it positively regulates receptor protein-tyrosine kinase ubiquitination in a manner dependent upon its variant SH2 and RING finger domains. Ubiquitination of receptor protein-tyrosine kinases terminates signaling by marking active receptors for degradation.

翻译修饰 - P22681 作为底物

Site PTM Type Enzyme
K7 Ubiquitination
S8 Phosphorylation
S15 Phosphorylation
S17 Phosphorylation
S20 Phosphorylation
S22 Phosphorylation
K58 Ubiquitination
K74 Ubiquitination
K105 Ubiquitination
T126 Phosphorylation
K134 Acetylation
Y141 Phosphorylation
K183 Ubiquitination
K197 Acetylation
K203 Ubiquitination
Y337 Phosphorylation
Y368 Phosphorylation
Y371 Phosphorylation P06213 (INSR) , P07948 (LYN) , P00533 (EGFR)
K424 Ubiquitination
S439 Phosphorylation
S441 Phosphorylation
S452 Phosphorylation
Y455 Phosphorylation
S483 Phosphorylation
S486 Phosphorylation
S492 Phosphorylation
S511 Phosphorylation
S512 Phosphorylation
S514 Phosphorylation
S520 Phosphorylation
K521 Ubiquitination
Y552 Phosphorylation
T568 Phosphorylation
K577 Ubiquitination
S583 Phosphorylation
S584 Phosphorylation
S589 Phosphorylation
S601 Phosphorylation
S619 Phosphorylation P17252 (PRKCA)
S623 Phosphorylation P17252 (PRKCA)
S639 Phosphorylation P17252 (PRKCA)
T640 Phosphorylation
S642 Phosphorylation P17252 (PRKCA)
T645 Phosphorylation
S646 Phosphorylation
S652 Phosphorylation
S667 Phosphorylation
S668 Phosphorylation
S669 Phosphorylation
Y674 Phosphorylation
S675 Phosphorylation
T698 Phosphorylation
Y700 Phosphorylation P43405 (SYK) , P06241 (FYN) , P00533 (EGFR) , P06239 (LCK) , P06213 (INSR) , P00519 (ABL1)
T702 Phosphorylation
S704 Phosphorylation
S705 Phosphorylation
T713 Phosphorylation
S714 Phosphorylation
S716 Phosphorylation
S717 Phosphorylation
Y731 Phosphorylation P12931 (SRC) , P08631 (HCK) , P43405 (SYK) , P06239 (LCK) , P00533 (EGFR) , P06241 (FYN)
Y735 Phosphorylation
T762 Phosphorylation
S767 Phosphorylation
Y774 Phosphorylation P00533 (EGFR) , P06241 (FYN) , P12931 (SRC) , P06239 (LCK) , P43405 (SYK)
T789 Phosphorylation
S791 Phosphorylation
S794 Phosphorylation
S797 Phosphorylation
S799 Phosphorylation
S804 Phosphorylation
S833 Phosphorylation
S900 Phosphorylation



Adapter protein that functions as a negative regulator of many signaling pathways that are triggered by activation of cell surface receptors. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, EGFR, CSF1R, EPHA8 and KDR and terminates signaling. Recognizes membrane-bound HCK, SRC and other kinases of the SRC family and mediates their ubiquitination and degradation. Participates in signal transduction in hematopoietic cells. Plays an important role in the regulation of osteoblast differentiation and apoptosis. Essential for osteoclastic bone resorption. The 'Tyr-731' phosphorylated form induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function. May be functionally coupled with the E2 ubiquitin-protein ligase UB2D3. In association with CBLB, required for proper feedback inhibition of ciliary platelet-derived growth factor receptor-alpha (PDGFRA) signaling pathway via ubiquitination and internalization of PDGFRA (By similarity).


Phosphorylated on tyrosine residues by ALK, EGFR, SYK, FYN and ZAP70 (By similarity). Phosphorylated on tyrosine residues in response to FLT1 and KIT signaling. Phosphorylated on tyrosine residues by INSR and FGR. Phosphorylated on several tyrosine residues by constitutively activated FGFR3. Not phosphorylated at Tyr-731 by FGFR3. Phosphorylated on tyrosine residues by activated CSF1R, PDGFRA and PDGFRB. Phosphorylated on tyrosine residues by HCK.

Ubiquitinated, leading to its degradation via the proteasome. Ubiquitination is negatively regulated by IFT20.


Cytoplasm. Cell membrane. Cell projection>Cilium. Golgi apparatus.
Note: Colocalizes with FGFR2 in lipid rafts at the cell membrane.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location

Forms homodimers; IFT20 promotes the formation of stable homodimers. Interacts (phosphorylated at Tyr-731) with PIK3R1. Associates with NCK via its SH3 domain. The phosphorylated C-terminus interacts with CD2AP via its second SH3 domain. Binds to UBE2L3. Interacts with adapters SLA, SLA2 and with the phosphorylated C-terminus of SH2B2. Interacts with EGFR, SYK and ZAP70 via the highly conserved Cbl-N region. Also interacts with SORBS1 and INPPL1/SHIP2. Interacts with phosphorylated LAT2 (By similarity). Interacts with CBLB. Interacts with ALK, AXL, BLK, FGR and FGFR2. Interacts with CSF1R, EPHB1, FLT1, KDR, PDGFRA and PDGFRB; regulates receptor degradation through ubiquitination. Interacts with HCK and LYN. Interacts with TEK/TIE2 (tyrosine phosphorylated). Interacts with SH3KBP1 and this interaction is inhibited in the presence of SHKBP1 (By similarity). Interacts with SIGLEC10 (By similarity). Interacts with IFT20.


The RING-type zinc finger domain mediates binding to an E2 ubiquitin-conjugating enzyme.

The N-terminus is composed of the phosphotyrosine binding (PTB) domain, a short linker region and the RING-type zinc finger. The PTB domain, which is also called TKB (tyrosine kinase binding) domain, is composed of three different subdomains: a four-helix bundle (4H), a calcium-binding EF hand and a divergent SH2 domain.


· Cellular Processes > Transport and catabolism > Endocytosis.   (View pathway)

· Environmental Information Processing > Signal transduction > ErbB signaling pathway.   (View pathway)

· Genetic Information Processing > Folding, sorting and degradation > Ubiquitin mediated proteolysis.   (View pathway)

· Human Diseases > Infectious diseases: Bacterial > Bacterial invasion of epithelial cells.

· Human Diseases > Cancers: Overview > Pathways in cancer.   (View pathway)

· Human Diseases > Cancers: Overview > Proteoglycans in cancer.

· Human Diseases > Cancers: Specific types > Chronic myeloid leukemia.   (View pathway)

· Organismal Systems > Immune system > T cell receptor signaling pathway.   (View pathway)

· Organismal Systems > Endocrine system > Insulin signaling pathway.   (View pathway)


产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)






Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.